Free Trial

Physiomics (PYC) Competitors

Physiomics logo
GBX 0.83 +0.03 (+3.88%)
As of 01/21/2025 12:06 PM Eastern

PYC vs. APTA, GENF, IXI, SNG, ROQ, TCF, EVG, MTFB, DEST, and BSFA

Should you be buying Physiomics stock or one of its competitors? The main competitors of Physiomics include Aptamer Group (APTA), Genflow Biosciences (GENF), IXICO (IXI), Synairgen (SNG), Roquefort Therapeutics (ROQ), Theracryf (TCF), Evgen Pharma (EVG), Motif Bio (MTFB), Destiny Pharma (DEST), and BSF Enterprise (BSFA). These companies are all part of the "biotechnology" industry.

Physiomics vs.

Aptamer Group (LON:APTA) and Physiomics (LON:PYC) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, community ranking, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment.

Aptamer Group has a beta of -0.52, suggesting that its share price is 152% less volatile than the S&P 500. Comparatively, Physiomics has a beta of 1.69, suggesting that its share price is 69% more volatile than the S&P 500.

Physiomics received 80 more outperform votes than Aptamer Group when rated by MarketBeat users.

CompanyUnderperformOutperform
Aptamer GroupN/AN/A
PhysiomicsOutperform Votes
80
55.56%
Underperform Votes
64
44.44%

In the previous week, Aptamer Group's average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.

Company Overall Sentiment
Aptamer Group Neutral
Physiomics Neutral

11.7% of Aptamer Group shares are held by institutional investors. 13.2% of Aptamer Group shares are held by company insiders. Comparatively, 4.2% of Physiomics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Aptamer Group has a net margin of 0.00% compared to Physiomics' net margin of -106.80%. Physiomics' return on equity of -149.67% beat Aptamer Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Aptamer GroupN/A -187.53% -44.96%
Physiomics -106.80%-149.67%-76.38%

Physiomics has lower revenue, but higher earnings than Aptamer Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aptamer Group£1.03M7.74-£7.01M-£0.08-5.19
Physiomics£900.71K1.87N/AN/AN/A

Summary

Aptamer Group beats Physiomics on 7 of the 10 factors compared between the two stocks.

Get Physiomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PYC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PYC vs. The Competition

MetricPhysiomicsBiotechnology IndustryMedical SectorLON Exchange
Market Cap£1.69M£177.42M£5.39B£2.04B
Dividend Yield6.20%3.64%5.37%5.16%
P/E Ratio-13.83131.1588.911,926.65
Price / Sales1.8719,225.171,290.81384,006.48
Price / Cash4.2113.0136.6029.21
Price / BookN/A9.234.963.08
Net IncomeN/A-£20.89M£117.89M£183.60M
7 Day Performance-6.52%0.14%1.68%1.24%
1 Month Performance18.71%2.31%3.63%3.43%
1 Year Performance-49.64%126.91%26.16%43.35%

Physiomics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PYC
Physiomics
N/AGBX 0.83
+3.9%
N/A-53.8%£1.69M£900,707.00-13.8310
APTA
Aptamer Group
N/AGBX 0.37
+8.8%
N/A-64.7%£7.10M£1.03M-4.6337Gap Up
High Trading Volume
GENF
Genflow Biosciences
N/AGBX 2.02
+4.9%
N/A+1.5%£7.06MN/A-201.905Gap Up
IXI
IXICO
N/AGBX 11.01
-4.3%
N/A-2.1%£5.32M£6M-275.2589Gap Up
High Trading Volume
SNG
Synairgen
N/AGBX 2.36
+5.1%
N/A-71.9%£4.75M£79,000.00-78.6734Positive News
Gap Down
ROQ
Roquefort Therapeutics
N/AGBX 3.64
-8.5%
N/A-42.2%£4.70M£637.00-364.009Gap Down
TCF
Theracryf
N/AGBX 0.85
+9.7%
N/AN/A£3.63MN/A-85.0010Gap Down
EVG
Evgen Pharma
N/AN/AN/AN/A£3.42MN/A-80.0010
MTFB
Motif Bio
N/AN/AN/AN/A£3.28MN/A-0.036
DEST
Destiny Pharma
N/AN/AN/AN/A£2.87M£135,028.00-50.0024Gap Down
High Trading Volume
BSFA
BSF Enterprise
N/AGBX 2.37
-5.4%
N/A-64.2%£2.45MN/A-118.3012Gap Up
High Trading Volume

Related Companies and Tools


This page (LON:PYC) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners